Physician profile
Mohammad Umar Khan
NPI 1306475561
$5,382.28
in general payments reported to CMS, 2019-2025
13 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.96 · 2021: $1,757 · 2022: $1,693 · 2023: $1,517 · 2024: $132 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902 · Travel and Lodging: $828 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.46 |
| Travel and Lodging | $827.77 |
| Education | $184.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,422.52 | 2021-2022 | |
| Paragon 28, INC. | $1,209.33 | 2021-2023 | Portfolio, Precision Guide Lapidus, Tenotac |
| Medical Device Business Services, INC. | $753.57 | 2021-2023 | |
| Stryker Corporation | $242.49 | 2024-2025 | Ortholoc 3di Crosscheck, Prostep Mica |
| Smith+Nephew, INC. | $158.97 | 2021-2025 | Grafix Pl |
| Integra Lifesciences Corporation | $136.84 | 2022 | |
| Depuy Synthes Sales INC. | $119.74 | 2020-2025 | Na |
| Organogenesis INC. | $119.70 | 2023 | Puraply Antimicrobial |
| Medtronic, INC. | $110.53 | 2022 | |
| Janssen Pharmaceuticals, INC | $34.78 | 2021 | |
| Kci USA, INC. | $29.11 | 2023 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Nexus Medical Technologies LLC | $28.50 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $16.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.